首页 > 市场调查报告书 > 医疗设备

医学影像诊断 CT/MRI/X光

造影乳房X光摄影市场规模、份额及成长分析（按应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1904372

造影乳房X光摄影市场规模、份额及成长分析（按应用、最终用户和地区划分）－2026-2033年产业预测

Contrast Enhanced Mammography Market Size, Share, and Growth Analysis, By Applications (Screening, Diagnosis), By End User (Hospital, Diagnostic Centres), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，造影乳房摄影市场规模将达到 24.4 亿美元，到 2025 年将达到 25.9 亿美元，到 2033 年将达到 41.2 亿美元，预测期（2026-2033 年）的复合年增长率为 6%。

造影增强乳房X光摄影（CEM）采用双能量技术，协同发挥数位乳房X光摄影和静脉造影显影剂的优势，在乳癌检测方面比传统方法具有更高的灵敏度。由于全球乳癌发生率不断上升，CEM 已成为首选的诊断方法。乳癌的危险因子包括年龄、肥胖、家族病史和各种生活方式选择，主要影响女性。早期发现至关重要，因为乳癌的症状从乳房肿块和大小变化到淋巴结肿大和呼吸问题等更严重的症状不等。乳癌发生率的上升凸显了对 CEM 等先进影像诊断技术的重要性和需求，显着推动了医疗保健产业的市场成长。

对比增强造影市场驱动因素

推动造影X光检查市场成长的关键因素是乳癌发生率的不断上升，乳癌是全球女性最常见的癌症。早期发现对于有效控制乳癌至关重要，并能提供多种治疗方案。患者通常接受手术、放射线治疗和各种药物治疗的联合治疗，包括荷尔蒙疗法、化疗和生物目标疗法。这些干预措施对于抑制癌症生长和减轻其影响至关重要，最终能够提高存活率并改善患者在对抗这种常见疾病中的预后。

造影乳房X光检查市场限制因素

对比增强造影X光乳房X光摄影的应用面临诸多挑战。首要挑战在于其成本高于传统乳房X光摄影，这主要是由于需要昂贵的设备、材料和专业培训。此外，提供这项先进影像技术的机构数量有限，导致患者难以获得相关服务，尤其对于居住在农村和偏远地区的患者。临床应用前需要获得监管部门的核准，这进一步增加了复杂性。核准流程可能耗时高成本，延迟产品上市。此外，儘管早期临床研究显示出令人鼓舞的结果，但由于缺乏关于该技术疗效和安全性的长期数据，一些医疗机构可能会在获得更多证据之前对其应用持谨慎态度。

造影乳房X光摄影市场的发展趋势

造影乳房X光摄影市场正经历显着增长，这主要得益于女性乳癌发病率的上升以及由此产生的对先进诊断解决方案的需求。效率更高、准确度更强、可靠性更高的创新影像技术不断涌现，显着提升了乳癌的检测和诊断能力。这一趋势反映了精准医疗的广泛发展趋势，医疗机构正寻求应用尖端技术，不仅以改善患者预后，还能简化诊断流程。随着人们对乳癌的认识不断提高以及技术的持续进步，预计该市场将继续扩张，为医学影像领域的相关人员带来新的机会。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

GE Healthcare（USA）
Siemens Healthineers（Germany）
Hologic, Inc.（USA）
Fujifilm Holdings Corporation（Japan）
Canon Medical Systems Corporation（Japan）
Philips Healthcare（Netherlands）
Carestream Health（USA）
Konica Minolta, Inc.（Japan）
Planmed Oy（Finland）
Sectra AB（Sweden）
Gamma Medica-Ideas, Inc.（USA）
SuperSonic Imagine（France）
iCAD, Inc.（USA）
ScreenPoint Medical（Netherlands）
DeepHealth（USA）
Lunit Inc.（South Korea）
CureMetrix, Inc.（USA）
Bracco Imaging SpA（Italy）
Guerbet（France）

结论与建议

简介目录

Product Code: SQMIG35G2123

Contrast Enhanced Mammography Market size was valued at USD 2.44 Billion in 2024 and is poised to grow from USD 2.59 Billion in 2025 to USD 4.12 Billion by 2033, growing at a CAGR of 6% during the forecast period (2026-2033).

Contrast Enhanced Mammography (CEM) utilizes a dual-energy technique that synergizes the advantages of digital mammography with intravenous contrast, proving to be more sensitive in breast cancer detection than traditional methods. The increasing prevalence of breast cancer globally positions CEM as a preferred diagnostic approach. Risk factors for breast cancer include age, obesity, family history, and various lifestyle choices, predominantly affecting females. Given that breast cancer symptoms can range from lumps and changes in breast size to more severe issues like lymph node swelling and respiratory problems, early detection is critical. This growing incidence of breast cancer underlines the importance and demand for advanced imaging technologies like CEM, thus significantly driving market growth in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Enhanced Mammography Market Segments Analysis

Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Enhanced Mammography Market

A significant factor propelling the growth of the Contrast Enhanced Mammography market is the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women on a global scale. Early detection plays a critical role in effectively managing breast cancer, allowing for a range of treatment options. Patients typically undergo a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in controlling cancer's proliferation and mitigating its impact, ultimately enhancing survival rates and improving patient outcomes in the battle against this pervasive disease.

Restraints in the Contrast Enhanced Mammography Market

The adoption of contrast-enhanced mammography faces several challenges, primarily due to its higher costs in comparison to traditional mammography, which stems from the expensive equipment, materials, and specialized training required. Additionally, the limited availability of facilities that offer this advanced imaging technique presents accessibility issues, especially for patients located in rural or remote areas. The necessity for regulatory approval prior to clinical use adds another layer of complexity, often involving prolonged and costly processes that can delay market entry. Moreover, although initial clinical studies have shown promising outcomes, the absence of extensive long-term data regarding the technology's efficacy and safety may lead some healthcare providers to be cautious about its implementation until further evidence is presented.

Market Trends of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market is witnessing significant growth, driven by the increasing incidence of breast cancer among women and the corresponding demand for advanced diagnostic solutions. Innovative imaging technologies are emerging, enhancing breast cancer detection and diagnostic capabilities with superior efficiency, accuracy, and reliability. This trend reflects a broader shift toward precision medicine, with healthcare providers seeking to adopt cutting-edge methods that not only improve patient outcomes but also streamline the diagnostic process. As awareness of breast cancer grows and technological advancements continue, the market is set to expand, offering new opportunities for stakeholders in the medical imaging field.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Contrast Enhanced Mammography Market Size by Applications & CAGR (2026-2033)

Market Overview
Screening
Diagnosis

Global Contrast Enhanced Mammography Market Size by End User & CAGR (2026-2033)

Market Overview
Hospital
Diagnostic Centres
Specialty Clinics
Others

Global Contrast Enhanced Mammography Market Size & CAGR (2026-2033)

North America (Applications, End User)
- US
- Canada
Europe (Applications, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Applications, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Applications, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Applications, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Konica Minolta, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sectra AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gamma Medica-Ideas, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SuperSonic Imagine (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iCAD, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ScreenPoint Medical (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DeepHealth (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lunit Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CureMetrix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments